Caseware UK (AP4) 2025.0.111 2025.0.111 2025-11-302025-11-301false2024-12-01falseNo description of principal activity1trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 08777520 2024-12-01 2025-11-30 08777520 2023-12-01 2024-11-30 08777520 2025-11-30 08777520 2024-11-30 08777520 c:Director1 2024-12-01 2025-11-30 08777520 d:CurrentFinancialInstruments 2025-11-30 08777520 d:CurrentFinancialInstruments 2024-11-30 08777520 c:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 08777520 c:FullAccounts 2024-12-01 2025-11-30 08777520 c:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 08777520 c:Micro-entities 2024-12-01 2025-11-30 08777520 e:PoundSterling 2024-12-01 2025-11-30 iso4217:GBP xbrli:pure

Registered number: 08777520









SUSHEN HAEMATOLOGY LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2025

 
SUSHEN HAEMATOLOGY LTD
REGISTERED NUMBER: 08777520

BALANCE SHEET
AS AT 30 NOVEMBER 2025

2025
2024
£
£


Fixed assets
50,753
52,267

Current assets
108,846
88,373

Creditors: amounts falling due within one year
(17,145)
(12,855)

Net current assets
 
 
91,701
 
 
75,518

Total assets less current liabilities
142,454
127,785


Net assets
142,454
127,785



Capital and reserves
142,454
127,785


Page 1

 
SUSHEN HAEMATOLOGY LTD
REGISTERED NUMBER: 08777520
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2025

Notes


General information

Sushen Haematology Ltd is a private company limited by shares and is incorporated and domiciled in England and Wales, registration number 08777520. The registered office is 56A Haverstock Hill, London NW3 2BH.


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


................................................
RAJEEV GUPTA
Director

Date: 17 August 2026

Page 2

 
SUSHEN HAEMATOLOGY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 105 the UK and the Republic of Ireland and the Companies Act 2006.

 
Page 3